Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

TikTok diet sparks concerns over powerful 'skinny jab' that can be bought online

The 'skinny jab' is usually used as a diabetes drug for weight loss and can be bought online without an NHS prescription but charities are warning it is a loaded gun

Daily Mirror

Weight loss jabs to be sold via high street chemists in England

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy

The Guardian - UK

Hollywood ‘skinny jab’ to be sold in UK

The drug is used by Hollywood A-listers to help them slim quickly

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Hollywood ‘skinny jab’ set to be sold in UK

The drug is used by Hollywood A-listers to help them slim quickly

The Independent UK

Diabetes sufferers fear shortages of drug after influencers say it helps lose weight

There are thousands of videos on TikTok that claim that you can miraculously lose weight by taking Ozempic, a medicine meant to be used by people with diabetes. As a result, there has been a massive rise in sales of Ozempic worldwide. Now, both doctors and people with diabetes are…

France 24

New diabetes drugs do not tackle root causes of obesity, experts warn

Doctors say preventing obesity by avoiding unhealthy food is better than trying to reverse its effects

The Guardian - UK

Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

WEKU

With weight-loss prescriptions causing shortage of diabetes drug Ozempic, diabetics struggle to find drug they depend on

TikTok videos about Ozempic as a weight-loss aid have gotten millions of views. The shortages are having a “ripple effect” on supplies of other diabetes medications.

Chicago Sun-Times

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Salon

How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

Investors Business Daily

Eli Lilly, insulin makers sued by California over prices

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Tribune News Service

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

New guidance: Use drugs, surgery early for obesity in kids

New guidelines suggest children struggling with obesity should be evaluated and treated early and aggressively

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

Axios

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investors Business Daily

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Novo Nordisk Stock Flashing Renewed Technical Strength

Novo Nordisk ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Tribune News Service

Patients complain some obesity care startups offer pills, and not much else

Many Americans turn to the latest big idea to lose weight — fad diets, fitness crazes, dodgy herbs and pills, bariatric surgery, just to name a few. They’re rarely the magic solution people dream of.

Salon

Concerns rise over obesity care startups

Concerns emerge over a wave of new startups offering access to drugs called GLP-1 agonists

Salon

Weight loss drug causing chaos on TikTok

A diabetes drug is all the rage among Hollywood’s elite, but folks who need the drug are struggling to get it

The Independent UK

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

Investors Business Daily

Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It

Twitter's new verification system shook Eli Lilly — leading LLY stock to skid Friday — after a fake account claimed "insulin is free now."

The Guardian - US

‘I miss eating’: the truth behind the weight loss drug that makes food repulsive

In Beverly Hills’ doctors offices, celebrities are clamoring for Ozempic prescriptions – but what are the costs of the supposed wonder drug?

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

328 stories

Amgen

324 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.